InsidersTradesSigma
Follow the 쿼드메디슨 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 쿼드메디슨 has recorded 4 reports. Market capitalisation: €63.7bn. The latest transaction was reported on 24 April 2026 (Purchase). Among the most active insiders: 김영흥. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Quad Medicine is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.